Results 141 to 150 of about 12,396 (213)

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. [PDF]

EBioMedicine
Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, Lutz TA, Le Foll C.   +11 more
europepmc   +1 more source

Leptin and G-protein coupled receptor (GPCR) signaling: Therapeutic potential in obesity. [PDF]

J Biol Chem
Sun X, Brueck L, Yang D, Sheets PL, Zhou B, Ren H.   +5 more
europepmc   +1 more source

Anti-CGRP receptor antibodies do not modulate trigeminal pain processing: indication for distinct mechanisms of CGRP pathway blockade. [PDF]

J Headache Pain
Peng KP, Basedau H, Messlinger K, May A.
europepmc   +1 more source

Amylin's role in nociception: study in amylin KO mice

, 2015
openaire   +2 more sources

From the pancreas to the amygdala: New brain area critical for ingestive and motivated behavior control exerted by amylin. [PDF]

iScience
Byun S, Maric I, Börchers S, Sotzen MR, Olekanma D, Hayes MR, Skibicka KP.   +6 more
europepmc   +1 more source

Metabolic dysfunction-associated steatotic liver disease and metabolic abnormalities are associated with age and serum des-acyl ghrelin among apparently healthy females: Findings from a whole gastroenteropancreatic hormones survey with path analysis. [PDF]

Biomed Rep
Lin CP, Chen HH, Chuang WC, Yeh C, Chen PY, Chen CY.   +5 more
europepmc   +1 more source

Cross-seeding of IAPP and Aβ42: A review of the molecular link between type 2 diabetes and Alzheimer's disease. [PDF]

Metab Brain Dis
Babu PR, Turner C, Ryznar R.
europepmc   +1 more source

Discovery of peptides as key regulators of metabolic and cardiovascular crosstalk. [PDF]

Cell Rep
Zhang Z, Svensson KJ.
europepmc   +1 more source

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways. [PDF]

Front Endocrinol (Lausanne)
Park C, Kim Y, Raygani S, Grunvald E.
europepmc   +1 more source